Hearing loss affects about 4% of people under 45 years of age and comprises a broad spectrum of clinical presentations (congenital or late-onset, conductive or sensorineural, and syndromic or nonsyndromic). Approximately 30% of genetically determined deafness is reported to occur in syndromic form and 70% in nonsyndromic form. This review highlights recent advances in the molecular and genetic basis of hearing loss, which will help in understanding the biology of normal and abnormal hearing.
Vestibular and hearing loss in genetic and metabolic disorders / P., Gasparini; X., Estivill; Fortina, Paolo. - In: CURRENT OPINION IN NEUROLOGY. - ISSN 1350-7540. - STAMPA. - 12:1(1999), pp. 35-39.
Vestibular and hearing loss in genetic and metabolic disorders.
FORTINA, PAOLO
1999
Abstract
Hearing loss affects about 4% of people under 45 years of age and comprises a broad spectrum of clinical presentations (congenital or late-onset, conductive or sensorineural, and syndromic or nonsyndromic). Approximately 30% of genetically determined deafness is reported to occur in syndromic form and 70% in nonsyndromic form. This review highlights recent advances in the molecular and genetic basis of hearing loss, which will help in understanding the biology of normal and abnormal hearing.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
